Semarion Secures $3.8M to Scale Next-Gen Cell Assay Tech
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials...